Antiretroviral pharmacology: special issues regarding pregnant women and neonates

Clin Perinatol. 2010 Dec;37(4):907-27, xi. doi: 10.1016/j.clp.2010.08.006.


Antiretrovirals may be used in pregnant women infected with the HIV and their newborns both for treatment of maternal HIV disease and for prevention of mother-to-child transmission of HIV. More than 25 antiretroviral agents in 5 classes have been approved, with new drugs and classes in development. This article reviews current knowledge of the pharmacology of these drugs during pregnancy and in the newborn period, highlighting those pharmacologic issues critical to the safe and effective use of antiretrovirals in these populations.

Publication types

  • Review

MeSH terms

  • Anti-Retroviral Agents / adverse effects
  • Anti-Retroviral Agents / pharmacokinetics
  • Anti-Retroviral Agents / therapeutic use*
  • Delivery, Obstetric
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / metabolism
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Milk, Human / metabolism
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Complications, Infectious / metabolism
  • Pregnancy Complications, Infectious / virology*
  • Teratogens
  • Tissue Distribution


  • Anti-Retroviral Agents
  • Teratogens